Checkmate Pharmaceuticals, Inc.
Checkmate Pharmaceuticals, Inc. (CMPI) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 48 transactions totaling $29.3M, demonstrating a bearish sentiment with -$2.3M in net insider flow. The most recent transaction on May 16, 2022 involved a sale of 95,800 shares valued at $1.0M.
CMPI Insider Activity Summary
Who Is Buying CMPI Stock?
No significant insider buying has been recorded for CMPI in the recent period.
Who Is Selling CMPI Stock?
No significant insider selling has been recorded for CMPI in the recent period.
Is Checkmate Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CMPI is bearish with an Insider Alignment Score of 46/100 and a net flow of -$2.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
CMPI Frequently Asked Questions
Understanding CMPI Insider Activity
Insider trading at Checkmate Pharmaceuticals, Inc. (CMPI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading CMPI stock, having executed 48 transactions in the past 90 days. The most active insider is Global Strategic Gp Ii, Ltd. Venbio (Executive), who has made 8 transactions totaling $11.5M.
Related Tools
Track Checkmate Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at CMPI file new Form 4 transactions